Study to Evaluate HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus

Clinical trial NCT07193459 · RECRUITING

Trial details

NCT number: NCT07193459
Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2025-08-12
Primary completion: 2026-10-10
Enrollment: 360

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.